TLR signaling: an emerging bridge from innate immunity to atherogenesis.
about
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor modelsMyeloid-related protein-8/14 is critical for the biological response to vascular injuryGenetics ignite focus on microglial inflammation in Alzheimer's diseaseAdiponectin as a potential biomarker of vascular diseaseIs Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease.Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjectsGenome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue.Suppression of LPS-induced inflammatory responses in macrophages infected with LeishmaniaToll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritisNucleotide oligomerization domain 1 is a dominant pathway for NOS2 induction in vascular smooth muscle cells: comparison with Toll-like receptor 4 responses in macrophages.Periodontal innate immune mechanisms relevant to atherosclerosis and obesity.Outer membrane protein a of Salmonella enterica serovar Typhimurium activates dendritic cells and enhances Th1 polarizationThe IL-33/ST2 pathway: therapeutic target and novel biomarker.Reconstituted high-density lipoprotein modulates activation of human leukocytes.Group X secretory phospholipase A2 enhances TLR4 signaling in macrophagesPathogen sensing pathways in human embryonic stem cell derived-endothelial cells: role of NOD1 receptors.DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice.Toll-like receptors are potential therapeutic targets in rheumatoid arthritis.Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages.Periodontal innate immune mechanisms relevant to atherosclerosis.An explanation for the paradoxical induction and suppression of an acute phase response by ethanol.Understanding the expression of Toll-like receptors in Asian Indians predisposed to coronary artery disease.Primary human monocyte differentiation regulated by Nigella sativa pressed oil.TB, or not TB: that is the question -- does TLR signaling hold the answer?Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.Metabolic syndrome: the danger signal in atherosclerosis.Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.Vasoactive intestinal peptide downregulates proinflammatory TLRs while upregulating anti-inflammatory TLRs in the infected cornea.Toll-like receptor 4-induced endoplasmic reticulum stress contributes to impairment of vasodilator action of insulinAntagonism of toll-like receptor 2 attenuates the formation and progression of abdominal aortic aneurysm.Toll-like receptors and human disease: lessons from single nucleotide polymorphisms.Leptin locally synthesized in carotid atherosclerotic plaques could be associated with lesion instability and cerebral emboliFlagellin-induced NADPH oxidase 4 activation is involved in atherosclerosisCoxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibilityImpact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in miceImpact of apoE genotype on oxidative stress, inflammation and disease risk.Atherosclerosis Risk in Communities (ARIC) Carotid MRI flow cytometry study of monocyte and platelet markers: intraindividual variability and reliability.RETRACTED: GCK is essential to systemic inflammation and pattern recognition receptor signaling to JNK and p38Expression and activity of the TLR4/NF-κB signaling pathway in mouse intestine following administration of a short-term high-fat diet
P2860
Q21245475-4A2FF8CA-A03B-44E4-931C-980A26CDEEAEQ24627504-627FA9A4-A22D-4A1E-BB67-3A5F238A8F63Q26781865-12C623B1-70FC-4120-901C-3255C7C6DDF9Q26821925-2E42DAA9-247A-4B64-9B10-65B65D3AB126Q27330629-E35540E5-65E9-4FEF-9888-1BEECD66DC0AQ29417090-3511D3B8-B7A4-4C0E-9D00-527B60E704DBQ30318873-F69ECE95-6985-4DFB-8032-C21825B6484BQ33638451-29F01EAD-9BE7-4800-82CF-21E7B2707891Q33669426-3BC5553B-630F-4D79-8D73-70D31690B84DQ33740199-BBBD058A-8AE3-4E33-89A4-626C1149EDC6Q34032309-009574EF-0B65-4114-9D11-E1A50402AA0DQ34083329-BDA4AB24-0D78-4A14-821A-93D4B4FB2E5CQ34282769-D537B028-3D15-43A2-BBFF-18864CB5B70CQ34776884-D215DCE5-34A2-4923-A4F1-5CCC133CC181Q34963571-21034AF4-2534-40A7-B43A-A8600EDC2DBEQ35058961-E999D8EB-B486-46A2-AA3B-99530D11B25FQ35137398-79C8B266-A7E9-472F-83E4-8F0DD6CFC43DQ35161203-667D4B99-8069-4F7B-8AB7-573E18ADA9A8Q35172878-ECE2788A-D6CC-450E-B099-D63C685C4402Q35544388-7D92E6C8-37CC-4838-9A12-C2DAE91C14F0Q35572063-C4E1EF1F-58B4-4C60-AE3E-D310928FA26AQ35574528-CCB20864-0478-4CE7-9A73-C3E21E5D5FFCQ35674383-FD989804-0B59-4B7C-A9A1-B4C09F464DD8Q35761058-79E1FF29-4A50-4DEC-8A0A-95D44B2CB36EQ35984329-8079377A-887E-44FD-B683-3BA41B13C96EQ36011463-4B29FF15-3D28-4D70-87F5-C2CC038338FAQ36012953-4E46E363-A03B-4275-8C69-AB80FF89B3E4Q36045565-800EEBA3-0BF6-4BA5-9D78-6EE19BB7412BQ36152154-7AB30A5A-A3C0-44AF-9032-920D3132FE0AQ36237092-803F45E8-2745-47D1-A860-61F8C71B4686Q36237998-37EDC7D6-EDC6-4EB9-B1AD-AE74B4836497Q36382348-B16B8FA8-232E-4358-9F01-D3B7BF598C0CQ36522619-2F1A9784-6E4E-4F36-AD3C-20C940473AC1Q36870913-F931D1E5-6C12-4423-B1AE-1F20A845A961Q36990137-95BD1445-4412-40D7-8B4A-50DA1D4D43AFQ37042467-F54F685A-625E-4BE2-A9D7-9D2E12D21CFEQ37059819-8A1219E1-1AA3-499B-8AC6-B511A968ECECQ37088352-F1EA0DC6-19CB-45FA-B29E-3D7D284881B6Q37132899-8CE0D5FD-5FA3-466D-81C4-24D8F66D7807Q37207326-793D0F9D-6258-4952-8D62-00384F5B2D28
P2860
TLR signaling: an emerging bridge from innate immunity to atherogenesis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
TLR signaling: an emerging bridge from innate immunity to atherogenesis.
@ast
TLR signaling: an emerging bridge from innate immunity to atherogenesis.
@en
type
label
TLR signaling: an emerging bridge from innate immunity to atherogenesis.
@ast
TLR signaling: an emerging bridge from innate immunity to atherogenesis.
@en
prefLabel
TLR signaling: an emerging bridge from innate immunity to atherogenesis.
@ast
TLR signaling: an emerging bridge from innate immunity to atherogenesis.
@en
P2093
P1476
TLR signaling: an emerging bridge from innate immunity to atherogenesis.
@en
P2093
Kathrin S Michelsen
Prediman K Shah
Terence M Doherty
P304
P356
10.4049/JIMMUNOL.173.10.5901
P407
P50
P577
2004-11-01T00:00:00Z